DIFFERENTIAL FETAL DEVELOPMENT OF THE O-DEMETHYLATION AND N-DEMETHYLATION OF CODEINE AND DEXTROMETHORPHAN IN MAN

被引:70
作者
LADONA, MG [1 ]
LINDSTROM, B [1 ]
THYR, C [1 ]
PENG, DR [1 ]
RANE, A [1 ]
机构
[1] ACAD HOSP UPPSALA,DIV CLIN PHARMACOL,S-75185 UPPSALA,SWEDEN
关键词
CYTOCHROME P450 IID6 AND IIIA; DEXTROMETHORPHAN; CODEINE; HUMAN FETAL LIVER;
D O I
10.1111/j.1365-2125.1991.tb03902.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Codeine and dextromethorphan were N-demethylated in human foetal liver microsomes at high rates which were close to the activities in adult livers. In contrast, foetal liver microsomes did not catalyze the O-demethylation of these drugs at mid-gestation. 2 The metabolic data were in accordance with the absence of P450IID6 and the presence of P450 IIIA as determined by Western blotting with anti-human P450 IID6 (MAb 114/2) and anti-rat P450 IIIA (PCN 2-13-1/C2) monoclonal antibodies, respectively. 3 The inhibitory effects of midazolam and dehydroepiandrosterone support the contention that the N-demethylase is a human foetal form of the cytochrome P450 IIIA family. Consistent with this we found that blotting with the MAb PCN 2-13-1/C2, which recognizes an epitope specific for the P450 III family, correlated well with the N-demethylase activities.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 37 条
[11]   METOPROLOL AND MEPHENYTOIN OXIDATION POLYMORPHISMS IN FAR EASTERN ORIENTAL SUBJECTS - JAPANESE VERSUS MAINLAND CHINESE [J].
HORAI, Y ;
NAKANO, M ;
ISHIZAKI, T ;
ISHIKAWA, K ;
ZHOU, HH ;
ZHOU, BJ ;
LIAO, CL ;
ZHANG, LM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) :198-207
[12]   POLYMORPHISMS OF OXIDATION AT CARBON CENTERS OF DRUGS AND THEIR CLINICAL SIGNIFICANCE [J].
IDLE, JR ;
SMITH, RL .
DRUG METABOLISM REVIEWS, 1979, 9 (02) :301-317
[13]  
KITADA M, 1987, J BIOL CHEM, V262, P13534
[14]   MOLECULAR-CLONING AND SEQUENCE-ANALYSIS OF CDNA CONTAINING THE ENTIRE CODING REGION FOR HUMAN-FETAL LIVER CYTOCHROME-P-450 [J].
KOMORI, M ;
NISHIO, K ;
OHI, H ;
KITADA, M ;
KAMATAKI, T .
JOURNAL OF BIOCHEMISTRY, 1989, 105 (02) :161-163
[15]   INVITRO CHARACTERIZATION OF THE HUMAN CYTOCHROME-P-450 INVOLVED IN POLYMORPHIC OXIDATION OF PROPAFENONE [J].
KROEMER, HK ;
MIKUS, G ;
KRONBACH, T ;
MEYER, UA ;
EICHELBAUM, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (01) :28-33
[16]   CYCLOSPORINE METABOLISM IN HUMAN-LIVER - IDENTIFICATION OF A CYTOCHROME-P-450III GENE FAMILY AS THE MAJOR CYCLOSPORINE-METABOLIZING ENZYME EXPLAINS INTERACTIONS OF CYCLOSPORINE WITH OTHER DRUGS [J].
KRONBACH, T ;
FISCHER, V ;
MEYER, UA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (06) :630-635
[17]  
KRONBACH T, 1989, MOL PHARMACOL, V36, P89
[18]   MONOCLONAL-ANTIBODY DIRECTED DETECTION OF CYTOCHROME-P-450 (PCN) IN HUMAN-FETAL LIVER [J].
LADONA, MG ;
PARK, SS ;
GELBOIN, HV ;
HAMMAR, L ;
RANE, A .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (24) :4735-4741
[19]   HUMAN-FETAL AND ADULT LIVER-METABOLISM OF ETHYLMORPHINE - RELATION TO IMMUNODETECTED CYTOCHROME-P-450 PCN AND INTERACTIONS WITH IMPORTANT FETAL CORTICOSTEROIDS [J].
LADONA, MG ;
SPALDING, DJM ;
EKMAN, L ;
LINDSTROM, B ;
RANE, A .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (19) :3147-3155
[20]   SINGLE-DOSE QUINIDINE TREATMENT INHIBITS METOPROLOL OXIDATION IN EXTENSIVE METABOLIZERS [J].
LEEMANN, T ;
DAYER, P ;
MEYER, UA .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 29 (06) :739-741